NANCY BERRY: Open Payments
NPI 1467187120 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 21 payments from 9 companies in 2025. Trend: 2023 $432 · 2024 $77 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $93 |
| ABBVIE INC. | 3 | $62 |
| PFIZER INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Ardelyx, Inc. | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
Products named: LINZESS, JARDIANCE, Wegovy, PREVNAR 20, Ozempic, MOUNJARO, AIRSUPRA, IBSRELA.
Industry payments across LA — which companies pay providers there.
